Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 183   

Articles published

AZN 4,467.41 +2.41 (0.05%)
price chart
These Figures Suggest That AstraZeneca plc Is Undervalued
At first glance, AstraZeneca (LSE: AZN) looks expensive. Indeed, at present levels Astra is currently trading at a forward P/E of 16.1, while peer GlaxoSmithKline is trading at a forward P/E of 16.
3 Reasons Why GlaxoSmithKline plc And AstraZeneca plc Are Worth Buying ...
While Pfizer's bid for AstraZeneca (LSE: AZN) (NYSE: AZN.US) did not come off last year, both it and sector peer GlaxoSmithKline (LSE: GSK) (NYSE: GSK.
How Safe Are GlaxoSmithKline plc And AstraZeneca plc's Dividends?
US) and AstraZeneca (LSE: AZN)(NYSE: AZN.US) have traditionally been seen as solid cash generators, but the shine wore off them a little as they both struggled with the expiry of patent protection on key drugs and the increase in competition from generics.
Should You Buy AstraZeneca plc Instead Of Hikma Pharmaceuticals Plc, BTG ...
2015 has been a rather mixed year thus far for the pharmaceutical sector. That's because, while the likes of AstraZeneca (LSE: AZN) (NYSE: AZN.US) and BTG (LSE: BTG) have seen their share prices fall by 1.5% and 1% respectively, superb gains have been ...
3 Reasons I Believe GlaxoSmithKline plc Is One Step Ahead Of AstraZeneca plc
Back in 2012, AstraZeneca (LSE: AZN) (NYSE: AZN.US) was priced for disaster. Investors expected the firm's profits to fall off the patent cliff, and the firm's shares were trading on a trailing P/E of around 6 times earnings, with a yield of more than 6%.
Is Indivior PLC The Perfect Partner For AstraZeneca plc In Your Portfolio?
Shares in Reckitt Benckiser spin-off, Indivior (LSE: INDV), were as much as 18% weaker today after the pharmaceutical company released a disappointing set of full-year results.
Which Is The Better Pick For Your Portfolio: GlaxoSmithKline plc Or ...
If you're struggling to choose between GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN), you're not alone. You see, Astra and Glaxo have adopted different strategies for the next few years.
AstraZeneca plc's "Buy" Rating Reiterated at Citigroup Inc. (AZN)
AstraZeneca plc logo Citigroup Inc. reaffirmed their buy rating on shares of AstraZeneca plc (LON:AZN) in a report issued on Wednesday.
Citigroup Inc. Reaffirms "Buy" Rating for AstraZeneca plc (AZN)  Intercooler
Citigroup Inc. Reiterates "Buy" Rating for AstraZeneca plc (AZN)  sleekmoney
Which Big Pharma Stock Is The Better Buy: AstraZeneca plc Or GlaxoSmithKline ...
Over the last year, the question of which Pharma major you should have bought has a relatively straightforward answer. That's because AstraZeneca (LSE: AZN) (NYSE: AZN.US) has seen its share price rise by a very impressive 23%, while GlaxoSmithKline's ...
Good Medicine: GlaxoSmithKline plc And AstraZeneca plc Can Help You Sleep ...  Yahoo Finance UK
AstraZeneca plc (AZN), Orca Pharma Enter RORγ Inhibitor Development ...
Orca Pharmaceuticals, a UK based biopharmaceutical company, and AstraZeneca (NYSE: AZN) announced a three year collaboration to develop inhibitors of retinoic acid�related orphan nuclear receptor gamma (RORγ).
AstraZeneca Enters Collaboration Deal With Orca Pharmaceuticals  London South East